Clinical Trial Update: Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of evogliptin on albuminuria in patients with type 2 diabetes and renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Renal Insufficiency
• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Type2 Diabetes Mellitus, Albuminuria | Phase 2 | Status: COMPLETED